# A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

> **NCT01975688** · PHASE1 · TERMINATED · sponsor: **GW Pharmaceuticals Ltd** · enrollment: 10 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Sativex

## Key facts

- **NCT ID:** NCT01975688
- **Lead sponsor:** GW Pharmaceuticals Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2016-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01975688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01975688, "A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01975688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*